Can BioNTech Take China Early-Stage Biotech Innovation Global?

 
• By Brian Yang

BioNTech is betting on China's innovative capabilities by inking multiple deals with local startups to expand its pipeline beyond mRNA vaccines.

Mainz, Rheinland-Pfalz, Germany-9. September 2020 Biontech building in Mainz with the sun shining and waving flags
BioNTech has signed on multiple Chinese biotechs in the past few months to expand its pipeline • Source: Florian Imbusch / Shutterstock.com

More from China

More from Focus On Asia